Discontinued — last reported Q4 '19
Products & Services · Operating Income
BTG Spec Pharma — Operating Income
Analysis
StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2019
Last reportedQ4 2019
Rolls up toOperating Income
How to read this metric
Higher operating income indicates strong product demand and effective cost management within the segment, while a loss suggests operational challenges or high investment phases.
Detailed definition
This metric measures the profitability of the BTG Specialty Pharmaceuticals segment by subtracting direct operating expe...
Peer comparison
Comparable to segment operating profit or EBIT reported by competitors in the specialty pharma or medical device sectors.
Metric ID:
bsx_segment_btg_spec_pharma_operating_income_lossSimilar Metrics at Other Companies
Frequently Asked Questions
- What does btg spec pharma — operating income mean?
- The profit or loss generated by the Specialty Pharmaceuticals segment before interest and taxes.